Literature DB >> 15564435

New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system.

Manuel Yepes1, Daniel A Lawrence.   

Abstract

Tissue-type plasminogen activator (tPA) is a highly specific serine proteinase that activates the zymogen plasminogen to the broad-specificity proteinase plasmin. Tissue-type plasminogen activator is found not only in the blood, where its primary function is as a thrombolytic enzyme, but also in the central nervous system (CNS), where it promotes events associated with synaptic plasticity and acts as a regulator of the permeability of the neurovascular unit. Tissue-type plasminogen activator has also been associated with pathological events in the CNS such as cerebral ischemia and seizures. Neuroserpin is an inhibitory serpin that reacts preferentially with tPA and is located in regions of the brain where either tPA message or tPA protein are also found, indicating that neuroserpin is the selective inhibitor of tPA in the CNS. There is a growing body of evidence demonstrating the participation of tPA in a number of physiological and pathological events in the CNS, as well as the role of neuroserpin as the natural regulator of tPA's activity in these processes. This review will focus on nonhemostatic roles of tPA in the CNS with emphasis on its newly described function as a regulator of permeability of the neurovascular unit and on the regulatory role of neuroserpin in these events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564435     DOI: 10.1177/153537020422901103

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  27 in total

1.  Tissue plasminogen activator, neuroserpin, and seizures.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

2.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.

Authors:  Enming J Su; Linda Fredriksson; Melissa Geyer; Erika Folestad; Jacqueline Cale; Johanna Andrae; Yamei Gao; Kristian Pietras; Kris Mann; Manuel Yepes; Dudley K Strickland; Christer Betsholtz; Ulf Eriksson; Daniel A Lawrence
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

Review 3.  Desmoteplase: discovery, insights and opportunities for ischaemic stroke.

Authors:  Robert L Medcalf
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 4.  Tissue plasminogen activator in central nervous system physiology and pathology.

Authors:  Jerry P Melchor; Sidney Strickland
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

5.  Plasticity-Related Gene Expression During Eszopiclone-Induced Sleep.

Authors:  Dmitry Gerashchenko; Ravi K Pasumarthi; Thomas S Kilduff
Journal:  Sleep       Date:  2017-07-01       Impact factor: 5.849

Review 6.  Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior.

Authors:  Antoine G Almonte; J David Sweatt
Journal:  Brain Res       Date:  2011-06-24       Impact factor: 3.252

7.  pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.

Authors:  Didier Belorgey; Peter Hägglöf; Maki Onda; David A Lomas
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

8.  Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.

Authors:  Hongqi Xin; Yi Li; Li Hong Shen; Xianshuang Liu; Xinli Wang; Jing Zhang; Siamak Pourabdollah-Nejad D; Chunling Zhang; Li Zhang; Hao Jiang; Zheng Gang Zhang; Michael Chopp
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

9.  Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence.

Authors:  Albert Chiou; Peter Hägglöf; Angel Orte; Allen Yuyin Chen; Paul D Dunne; Didier Belorgey; Susanna Karlsson-Li; David A Lomas; David Klenerman
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

10.  Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury.

Authors:  Krishna Kumar Veeravalli; Venkata Ramesh Dasari; Andrew J Tsung; Dzung H Dinh; Meena Gujrati; Dan Fassett; Jasti S Rao
Journal:  Neurochem Res       Date:  2009-01-17       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.